About
Vaccibody ASA is a Norwegian biotechnology company that develops vaccines and immunotherapies using a DNA-based modular platform targeting antigens to antigen-presenting cells, focusing on personalized cancer vaccines and infectious disease vaccines.
Explore Vaccibody ASA's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.